Longeveron Inc logo

LGVN - Longeveron Inc Share Price

$7.9 -0.1  -1.3%

Last Trade - 01/03/21

Sector
Healthcare
Size
Small Cap
Market Cap £195.3m
Enterprise Value £194.6m
Revenue £4.52m
Position in Universe 4144th / 6633
Bullish
Bearish
Unlock LGVN Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -21.0%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.000 0.000 2.13 5.64 +164.2%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 September 2020,Longeveron Inc revenues increased 17% to $4.4M. Net lossdecreased 5% to $2.4M. Revenues reflect Grant incomeincrease of 37% to $3.6M. Lower net loss reflects Salesdecrease of 22% to $140K (expense), General andadministrative - Balancing v decrease of 1% to $1.4M(expense). Basic Earnings per Share excluding ExtraordinaryItems remained flat at -$0.13.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

LGVN Revenue Unlock LGVN Revenue

Net Income

LGVN Net Income Unlock LGVN Revenue

Normalised EPS

LGVN Normalised EPS Unlock LGVN Revenue

PE Ratio Range

LGVN PE Ratio Range Unlock LGVN Revenue

Dividend Yield Range

LGVN Dividend Yield Range Unlock LGVN Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
LGVN EPS Forecasts Unlock LGVN Revenue
Profile Summary

Longeveron LLC is a clinical stage biotechnology company. The Company is focused on developing cellular therapies for specific aging-related and life-threatening conditions. Its lead investigational product is the LOMECEL-B cell-based therapy product (Lomecel-B), which is derived from culture-expanded medicinal signaling cells (MSCs) that are sourced from bone marrow of young healthy adult donors. It is sponsoring clinical trials in various indications, including Aging Frailty, Alzheimer’s disease (AD), the Metabolic Syndrome, Acute Respiratory Distress Syndrome (ARDS) and hypoplastic left heart syndrome (HLHS). It is developing Lomecel-B as a therapy for Aging Frailty and is being designed to reduce inflammation associated with Aging Frailty and to promote an anti-inflammatory state by releasing anti-inflammatory molecules, which can promote physiological restoration to a more normal state. It is conducting two multicenter trials in the United States (U.S.) for Aging Frailty.

Directors
Last Annual December 31st, 2019
Last Interim September 30th, 2020
No. of Shareholders: n/a
No. of Employees: 12
Sector Healthcare
Industry Biotechnology & Medical Research
Index Nasdaq Composite ,
Exchange NASDAQ Capital Market
Shares in Issue 34,409,745
Free Float (0.0%)
Eligible for
ISAs
SIPPs
LGVN Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for LGVN
Upcoming Events for LGVN
Frequently Asked Questions for Longeveron Inc
What is the Longeveron Inc share price?

As of 01/03/21, shares in Longeveron Inc are trading at $7.9, giving the company a market capitalisation of £195.3m. This share price information is delayed by 15 minutes.

How has the Longeveron Inc share price performed this year?

Shares in Longeveron Inc are currently trading at $7.9 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Longeveron Inc price has moved by % over the past year.

What are the analyst and broker recommendations for Longeveron Inc?

There are no analysts currently covering Longeveron Inc.

When will Longeveron Inc next release its financial results?

Longeveron Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the Longeveron Inc dividend yield?

Longeveron Inc does not currently pay a dividend.

Does Longeveron Inc pay a dividend?

Longeveron Inc does not currently pay a dividend.

When does Longeveron Inc next pay dividends?

Longeveron Inc does not currently pay a dividend.

How do I buy Longeveron Inc shares?

To buy shares in Longeveron Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Longeveron Inc?

Shares in Longeveron Inc are currently trading at $7.9, giving the company a market capitalisation of £195.3m.

Where are Longeveron Inc shares listed? Where are Longeveron Inc shares listed?

Here are the trading details for Longeveron Inc:

Country of listing: United States
Exchange: NAQ
Ticker Symbol: LGVN
What kind of share is Longeveron Inc?

Based on an overall assessment of its quality, value and momentum, Longeveron Inc is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Longeveron Inc share price forecast 2021?

We were not able to load any forecast data for Longeveron Inc.

How can I tell whether the Longeveron Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Longeveron Inc. Over the past six months, the relative strength of its shares against the market has been %. At the current price of $7.9, shares in Longeveron Inc are trading at 10.04% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Longeveron Inc PE Ratio?

We were not able to find PE ratio data for Longeveron Inc.

Who are the key directors of Longeveron Inc?

We were unable to find the directors for Longeveron Inc.

Who are the major shareholders of Longeveron Inc?

Here are the top five shareholders of Longeveron Inc based on the size of their shareholding:

Hare (Joshua M) Individual Investor
Percentage owned: 5.21% (157k shares)
Borger (Erin) Individual Investor
Percentage owned: 0.59% (17.8k shares)
Hare (Neil E) Individual Investor
Percentage owned: 0.03% (0.894k shares)
Similar to LGVN
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.